FY25 revenue missed guidance amid platform delays, with risks from customer concentration. Read more about SMCI stock here.

Eli Lilly CEO David Ricks is confident that weight loss med Zepbound is gaining market share at the expense of Wegovy, even as its rival strikes deals with CVS and Hims & Hers pharmacies.

“It’s a dynamic time right now, and off-price is a good place to be in retail because consumers want the best value,” Chris ...

In the heart of Winston-Salem sits a sprawling indoor universe where bargain hunters and curiosity seekers converge in a ...

In accordance with its policy in favor of employee shareholding, TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) (the "Corporation") is implementing its annual capital increase reserved for ...

Challenging markets ahead? Explore Meghan Shue's investment strategy insights, sector picks & mild recession forecasts.

Hybrid-electric airplane maker Heart Aerospace will relocate its headquarters and operations to Los Angeles from Sweden's Gothenburg, in a bid to boost its product development in the United States, ...

The latest planned building looks very similar to the image released 13 months ago, which was also called Derby MADE ...

Farm Zero has signed a five-year lease for 9,023 square feet at 125 South Wacker Drive, a 31-story tower across the street ...

Out of all the 2021 Atlanta Braves who have moved on to other teams, losing beloved reliever A.J. Minter to the rival New ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

In the Bank Satisfaction Rankings 2025, Saigon-Hanoi Bank (SHB) not only makes it to the top 10 but also stands out as the ...